ExodusPoint Capital Management »

Black Diamond Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.8M 873k 4.35
2024-03-31 $586k 116k 5.07
2021-09-30 $181k 21k 8.45
2021-06-30 $568k 47k 12.19

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Johnson & Johnson Put Option (JNJ)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
NiSource (NI)
CMS Energy Corporation (CMS)
PPL Corporation (PPL)
Tesla Motors Put Option (TSLA)
Mondelez Intl Cl A (MDLZ)
Becton, Dickinson and (BDX)
Exelon Corporation (EXC)

View all positions for ExodusPoint Capital Management

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Bellevue Group
Vestal Point Capital
NEA Management Company
BlackRock
BlackRock
Vanguard Group
Ikarian Capital
Tang Capital Management
Siren
Geode Capital Management
ExodusPoint Capital Management
Citadel Advisors
Kennedy Capital Management
Point72 Asset Management

View all funds holding Black Diamond Therapeutics